Oncolytics Biotech Inc ONCY

Dr. Jean-Pierre Bizzari

[pelaboost]

His name was mentioned on STW; so presumably he is now with us in some capacity.

He has led global clinical development conducting over 25 Phase 3 trials. Most or all with Celgene.

I especially like that he has a degree in mathematics. That should be very helpful around the office.

[itntdf]

he shows up on oncy's website under scientific advisory board members.  also: Dr. Jean P. Bizzari, MD, is an Independent Director at Halozyme Therapeutics, Inc., a Chairman at NETRIS Pharma SAS and a President & Director at Synergie Lyon Cancer.   He is on the Board of Directors at Aprea Therapeutics, Inc., ADC Therapeutics SA, Halozyme Therapeutics, Inc., European

[Quantum41]

Dr Bizzari, seems to be also on the advisory board of this company, researching pancreatic cancer: "I am excited about the opportunity to partner with such an esteemed group of scientific advisors who are committed to supporting the development of IMM-101 to treat immunologically cold tumors, including pancreatic cancer,” said Josefine Roemmler-Zehrer, MD, Associate Professor, and Immodulon’s

[Azzak34]

Pfft, another loser added to a board of no name failures! Failing companies bring in weak, inexperienced "doctors" when they have nothing going for them!!! Wait, if this is true the converse is also true? Can't mean...... can it? 

[venture009]

If we are adding more people doesn't this suggest they aren't expectuing a deal any time soon? Make a deal please. This circus has gone on far too long. 

[Azzak34]

Euggh. Have you read who this guy is and what he's done? He's now involved with our company. Read our advisor and director list then spend a minute investigating who they are and what they've achieved.  You dopes want to win the lottery.... buy a ticket and wait for your numbers to be called.  People, right now all over the world, are dying in their thousands from war

[venture009]

Our current BofD have very impressive credentials too, and how has that worked out so far? Reverse split, Anson deal errosion of shareholder value, many medical officers and where is de Guttadauro, etc. For once I would like this company to focus completely on increasing the share price and not expanding the science. 25 years already! Announcing a partner deal or a buyout would be the minimum

[Azzak34]

Our company is testing a reovirus. Only 1 oncolytic reovirus has ever been approved to fight cancer in 1 indication, melanoma. We are building our case to be the 2nd in at least 2 indications. Results have been great, missteps have been made but the trajectory, over time, has been forward. Mistakes in R&D in any industry are not corrected quickly, never mind years long studies and extensive

[TMAZZ21]

Yea we should get there by the 22nd century just another 76 years and 16 days! Will get there but slow and steady! So goes this sinking ship!!  :( 

[Azzak34]

You feel you've made a bad investment? Sounds like a you problem. 

[inthno]

It's your impatience that is the problem.... wow I guess we can justify anything, we had mbc and have been patient for over 5 years since they had fda approval with a spa. How about someone not exercising options that were supposedly in the money and letting them go so you don't have to hold shares and then getting awarded another 350,000 options. Why do they deserve this now when the sp

[Azzak34]

All you do is whine and compain.  So you got in too early, you hung on and hung on and the company made mistakes? Again, sounds like a you problem. You've made an investment that you're not happy with? That's.a.you.problem!!!  And don't pretend you're some sort of benevolent force for the poor downtrodden shareholders, you'd trample over everyone here for a few

[inthno]

Yes I admit I do have an issue with what has happened and what is going on but is what it is and that is on me. Quick question AZZAK34 and putting all personalities aside I would like your honest opinion. Do you think that the granting of all the options to the execs that happened yesterday was justified considering all that has happened and where the sp is.

[Azzak34]

No I don't. You mustn't confuse my stance as tacit approval of the performance thus far. However, Matt and the board have produced excellent results in the trials in the last 18 months. They managed to get Pancan as a partner and an additional $5 million dollar grant. They have kept us solvent, albeit with ATM usage and partnering with a potentially shady bunch of character while a whole

[inthno]

Thank you AZZAK as IMO I think that this post of yours was one of the best and most realistic that you have posted so thanks for that and GL to all hoping for better times and transparency ahead.

[canadafan]

Re azz34 I also support your well thought out post. Many enjoy focusing on only negatives. Yes there are many, However as you said, they have been able to get this far. said many many times. Next few months will be interesting. Now with change of both executive & a new science advisor, could become yet again a new starting point. Built on top of the in place realrptionships & results with.

[inthno]

Yes the science is good but so many small trials is hard for the end game. CF, its not always about focusing on the negatives as you always give managment every break in the book no matter what and supporting every turn they make no matter what the cost. You supported the pp, you supported a tripling of managment compensation and even suggested that Matt had exercised his 350,000 options that he

[Noteable]

The real question is whether Bizzari has the capacity to provide his statistical prowness to a small population clinical trial involved in the treatment of a orphan/rare disease. Unlike traditional clinical trials, the inherent difficulty in powering  orphan/rare disease clinical trials exist because of small population size, a limited understanding of disease

[pelaboost]

Dr. Bizzari and PanCAN have more than a nodding acquaintance. It was a while back; nevertheless these connections keep me interested. Cheers